The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Protein Nanoparticles: Promising Platforms for Drug Delivery Applications
Abstract
The development of drug delivery systems using nanoparticles as carriers for small and large therapeutic molecules remains a rapidly growing area of research. The advantages of using proteins to prepare nanoparticles for drug delivery applications include their abundance in natural sources, biocompatibility, biodegradability, easy synthesis process, and cost-effectiveness. In contrast to several particulate systems like nanoparticles from metallic and inorganic/synthetic sources, the protein nanoparticles do not have limitations such as potential toxicity, large size, accumulation, or rapid clearance from the body. In addition, protein-based nanoparticles offer the opportunity for surface modification by conjugation of other protein and carbohydrate ligands. This enables targeted delivery to the desired tissue and organ, which further reduces systemic toxicity. The use of protein nanoparticles for such applications could therefore prove to be a better alternative to maneuver and improve the pharmacokinetic and pharmacodynamic properties of the various types of drug molecules. In this review, while focusing on the properties of a few proteins such as the silk protein fibroin, we attempt to provide an overview of the existing protein-based nanoparticles. We discuss various methods for the synthesis of this class of nanoparticles. The review brings forth some of the factors that are important for the design of this class of nanoparticles and highlights the applications of the nanoparticles obtained from these proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–232 of 232
Liu, B., Wu, P., Sha, H., Qian, H., Wang, Q., Yang, Y., Yang, M., Bian, X., & Lei, C. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s100678 · Cited by 54
Zhao, L., Zhou, Y., Gao, Y., Ma, S., Zhang, C., Li, J., Wang, D., Li, X., Li, C., Liu, Y., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.02.018 · Cited by 53
Elgohary, M. M., Helmy, M. W., Mortada, S. M., & Elzoghby, A. O. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0097 · Cited by 53
Curcumin-functionalized silk biomaterials for anti-aging utility
Yang, L., Zheng, Z., Qian, C., Wu, J., Liu, Y., Guo, S., Li, G., Liu, M., Wang, X., & Kaplan, D. L. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.01.115 · Cited by 51
Study of magnetic silk fibroin nanoparticles for massage-like transdermal drug delivery
Chen, A., Chen, L.-Q., Wang, S., Wang, Y., & Zha, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s85999 · Cited by 50
Therapeutic applications and properties of silk proteins fromBombyx mori
Joseph, B., & Raj, S. J. (2012) · Frontiers in Life Science · doi:10.1080/21553769.2012.760491 · Cited by 50
Nanotechnological Strategies for Therapeutic Targeting of Tumor Vasculature
Ding, Y., Li, S., & Nie, G. (2013) · Nanomedicine · doi:10.2217/nnm.13.106 · Cited by 47
Phuong, P. T. T., Lee, S., Lee, C., Seo, B., Park, S., Oh, K. T., Lee, E. S., Choi, H., Shin, B. S., & Youn, Y. S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.07.016 · Cited by 47
Hearst, S. M., Walker, L. R., Shao, Q., López, M. I. S., Raucher, D., & Vig, P. J. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.025 · Cited by 45
Kayani, Z., Firuzi, O., & Bordbar, A. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.10.041 · Cited by 44
Triple therapy-based targeted nanoparticles for the treatment ofHelicobacter pylori
Ramteke, S., Ganesh, N., Bhattacharya, S., & Jain, N. K. (2008) · Journal of drug targeting · doi:10.1080/10611860802295839 · Cited by 42
Using a Novel MicroRNA Delivery System to Inhibit Osteoclastogenesis
Yao, Y., Jia, T., Pan, Y., Gou, H., Li, Y., Sun, Y., Zhang, R., Zhang, K., Lin, G., Xie, J., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16048337 · Cited by 42
Dautzenberg, H., Zintchenko, A., Koňák, Č., et al. (2001) · Langmuir · doi:10.1021/la001779t · Cited by 41
Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles
Wernig, K., Griesbacher, M., Andreae, F., Hajos, F., Wagner, J., Mosgoeller, W., & Zimmer, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.06.005 · Cited by 40
A Sight on Protein-Based Nanoparticles as Drug/Gene Delivery Systems
Salatin, S., Jelvehgari, M., Dizaj, S. M., & Adibkia, K. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.28 · Cited by 40
Ryu, J. S., & Raucher, D. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.974546 · Cited by 38
Guo, Z., Wang, F., Yang, D., Yao, L., Yu, X., Fu, D., Li, J., & Jin, C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166769 · Cited by 38
Parisi, O. I., Fiorillo, M., Scrivano, L., Sinicropi, M. S., Dolce, V., Iacopetta, D., Puoci, F., & Cappello, A. R. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00746 · Cited by 36
Absence of Immune Responses with Xenogeneic Collagen and Elastin
Bayrak, A., Prüger, P., Stock, U. A., & Seifert, M. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0394 · Cited by 35
Recombinant Protein Materials for Bioengineering and Nanomedicine
Corchero, J. L., Vázquez, E., García‐Fruitós, E., Ferrer‐Miralles, N., & Villaverde, A. (2014) · Nanomedicine · doi:10.2217/nnm.14.153 · Cited by 35
Biosafe Nanoscale Pharmaceutical Adjuvant Materials
Jin, S., Li, S., Wang, C., Liu, J., Yang, X., Wang, P. C., Zhang, X., & Liang, X. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1898 · Cited by 35
Segura, S., Gamazo, C., Irache, J. M., & Espuelas, S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00890-06 · Cited by 35
Xu, J., & Amiji, M. M. (2012) · Journal of Visualized Experiments · doi:10.3791/3612 · Cited by 32
Pal, A., Bajpai, J., & Bajpai, A. K. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.03.025 · Cited by 32
RGD modified albumin nanospheres for tumour vasculature targeting
Dubey, P. K., Singodia, D., Verma, R. K., & Vyas, S. P. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01180.x · Cited by 30
Yu, X., Hou, J., Shi, Y., Su, C., & Zhao, L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s117066 · Cited by 28
T helper 2 biased de novo immune response to Keyhole Limpet Hemocyanin in humans
Spazierer, D., Skvara, H., Dawid, M., Fallahi, N., Gruber, K., Rose, K., Lloyd, P. M., Heuerding, S., Stingl, G., & Jung, T. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03177.x · Cited by 25
Amphiphilic protein micelles for targeted in vivo imaging
Kim, W., Brady, C. M., & Chaikof, E. L. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.04.011 · Cited by 22
Developing a Dissociative Nanocontainer for Peptide Drug Delivery
Kelly, P., Anand, P., Uvaydov, A., Chakravartula, S. V. S., Sherpa, C., Pires, E., O’Neil, A., Douglas, T., & Holford, M. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph121012543 · Cited by 21
Sugihara, T., Mie, M., & Kobatake, E. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.12.023 · Cited by 13
Chemical modification of enveloped viruses for biomedical applications
Bhuket, P. R. N., Luckanagul, J. A., Rojsitthisak, P., & Wang, Q. (2018) · Integrative Biology · doi:10.1039/c8ib00118a · Cited by 8
Scheicher, B., Lorenzer, C., Gegenbauer, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164149 · Cited by 7
Cited by
Multifunctional biomolecule nanostructures for cancer therapy
Wang, J., Li, Y., & Nie, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00315-x · Cited by 488
Biocompatibility of nanomaterials and their immunological properties
Kyriakides, T. R., Raj, A., Tseng, T. H., Xiao, H., Nguyen, R., Mohammed, F. S., Halder, S., Xu, M., Wu, M. J., Bao, S., et al. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe5fa · Cited by 389
Recent advances in natural polymer-based drug delivery systems
Tong, X., Pan, W., Su, T., Zhang, M., Dong, W., & Qi, X. (2020) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2020.104501 · Cited by 349
Nanoparticles: Synthesis, characteristics, and applications in analytical and other sciences
Sajid, M., & Płotka-Wasylka, J. (2020) · Microchemical Journal · doi:10.1016/j.microc.2020.104623 · Cited by 285
Metadata
- Authors
- Jain, A., Singh, S. K., Arya, S. K., Kundu, S. C., & Kapoor, S.
- Venue
- ACS Biomaterials Science & Engineering
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-11-02
- Volume
- 4
- Issue
- 12
- Pages
- 3939-3961
- ISSN
- 2373-9878 (ISSN-L)
- OpenAlex
- W2899515413
- Cited by
- 308
- References
- 232
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.